Cargando…
Exportin 1 inhibition as antiviral therapy
Coronavirus 2019 (COVID-19; caused by Severe Acute Respiratory Syndrome Coronavirus 2; SARS-CoV-2) is a currently global health problem. Previous studies showed that blocking nucleocytoplasmic transport with exportin 1 (XPO1) inhibitors originally developed as anticancer drugs can quarantine key vir...
Autores principales: | Uddin, Md. Hafiz, Zonder, Jeffrey A., Azmi, Asfar S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305737/ https://www.ncbi.nlm.nih.gov/pubmed/32569833 http://dx.doi.org/10.1016/j.drudis.2020.06.014 |
Ejemplares similares
-
Circular RNAs in acute myeloid leukemia
por: Singh, Vijendra, et al.
Publicado: (2021) -
Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration
por: Azmi, Asfar S., et al.
Publicado: (2017) -
Association of ALDH1A1-NEK-2 axis in cisplatin resistance in ovarian cancer cells
por: Uddin, Md. Hafiz, et al.
Publicado: (2020) -
Therapeutic Targeting of Exportin-1 in Childhood Cancer
por: Galinski, Basia, et al.
Publicado: (2021) -
Importins and exportins in cellular differentiation
por: Okada, Norihisa, et al.
Publicado: (2008)